These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16504349

  • 1. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ, Leenaars MP, Guzylack-Piriou L, Summerfield A, Hendriksen CF, McCullough KC.
    Vaccine; 2006 Apr 12; 24(16):3076-83. PubMed ID: 16504349
    [Abstract] [Full Text] [Related]

  • 2. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.
    Fernandez V, Andersson J, Andersson U, Troye-Blomberg M.
    Eur J Immunol; 1994 Aug 12; 24(8):1808-15. PubMed ID: 8056039
    [Abstract] [Full Text] [Related]

  • 3. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG, Culbertson NJ.
    J Immunol; 1985 Jul 12; 135(1):185-91. PubMed ID: 2582031
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C, Umetsu D, Schneeberger E, Geha RS.
    J Immunol; 1984 Mar 12; 132(3):1144-50. PubMed ID: 6607279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
    Jahn S, Kiessig ST, Grunow R, von Baehr R.
    Allerg Immunol (Leipz); 1987 Mar 12; 33(2):89-94. PubMed ID: 2959130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, Leccia MT, Lesimple T, Wijdenes J, Bartholeyns J, Fridman WH, Salcedo M, Ferries E, Tartour E.
    J Immunother; 2008 Jan 12; 31(1):101-12. PubMed ID: 18157017
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody.
    Rowe J, Poolman JT, Macaubas C, Sly PD, Loh R, Holt PG.
    Vaccine; 2004 Sep 28; 22(29-30):3986-92. PubMed ID: 15364448
    [Abstract] [Full Text] [Related]

  • 12. Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics.
    Wullner D, Zhou L, Bramhall E, Kuck A, Goletz TJ, Swanson S, Chirmule N, Jawa V.
    Clin Immunol; 2010 Oct 28; 137(1):5-14. PubMed ID: 20708973
    [Abstract] [Full Text] [Related]

  • 13. Enhancing the sensitivity of assays to detect T cell reactivity: the effect of cell separation and cryopreservation media.
    Tree TI, Roep BO, Peakman M.
    Ann N Y Acad Sci; 2004 Dec 28; 1037():26-32. PubMed ID: 15699490
    [Abstract] [Full Text] [Related]

  • 14. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
    Coombes L, Stickings P, Tierney R, Rigsby P, Sesardic D.
    J Immunol Methods; 2009 Oct 31; 350(1-2):142-9. PubMed ID: 19761770
    [Abstract] [Full Text] [Related]

  • 15. A restricted component of T cell help in pokeweed mitogen-stimulated humans peripheral blood cell cultures.
    Macy E, Stevens RH.
    J Immunol; 1980 Feb 31; 124(2):752-9. PubMed ID: 6965390
    [Abstract] [Full Text] [Related]

  • 16. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G, Hense B, Laws HJ, Groeger M, MacKenzie CR, Göbel U.
    Klin Padiatr; 2007 Feb 31; 219(6):355-60. PubMed ID: 18050047
    [Abstract] [Full Text] [Related]

  • 17. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ, He HX, Zhuang H.
    J Gastroenterol Hepatol; 2006 Jun 31; 21(6):970-6. PubMed ID: 16724980
    [Abstract] [Full Text] [Related]

  • 18. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK, Munro AJ.
    Clin Exp Immunol; 1981 Oct 31; 46(1):171-7. PubMed ID: 6978212
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR.
    Tassignon J, Burny W, Dahmani S, Zhou L, Stordeur P, Byl B, De Groote D.
    J Immunol Methods; 2005 Oct 30; 305(2):188-98. PubMed ID: 16157348
    [Abstract] [Full Text] [Related]

  • 20. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M.
    J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.